John F Sheridan Tandem Diabetes Care Inc (TNDM) insider trading activity

John F Sheridan is PRESIDENT & CEO of TANDEM DIABETES CARE INC. Currently has a direct ownership of 111,963 shares of TNDM, which is worth approximately $1.36 Million. The most recent transaction as insider was on May 27, 2022, when has been sold 407 shares (Common Stock) at a price of $70.81 per share, resulting in proceeds of $28,820. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 112K

16.23% 3M change

124.98% 12M change

Total Value Held $1.36 Million

John F Sheridan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 27 2022	SELL Payment of exercise price or tax liability	$28,820 $70.81 p/Share	407 Reduced 3.18%	12,375 Common Stock
May 27 2022	BUY Exercise of conversion of derivative security	-	820 Added 6.03%	12,782 Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$116,092 $73.85 p/Share	1,572 Reduced 11.88%	11,656 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	-	3,170 Added 19.33%	13,228 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	$18,718 $61.17 p/Share	306 Added 2.49%	11,962 Common Stock
May 09 2022	BUY Open market or private purchase	$174,750 $69.9 p/Share	2,500 Added 19.91%	10,058 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$31,930 $112.43 p/Share	284 Reduced 3.62%	7,558 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	819 Added 9.46%	7,842 Common Stock
Nov 29 2021	SELL Payment of exercise price or tax liability	$52,772 $129.66 p/Share	407 Reduced 5.48%	7,023 Common Stock
Nov 29 2021	BUY Exercise of conversion of derivative security	-	820 Added 9.94%	7,430 Common Stock
Aug 27 2021	SELL Payment of exercise price or tax liability	$44,896 $110.31 p/Share	407 Reduced 5.8%	6,610 Common Stock
Aug 27 2021	BUY Exercise of conversion of derivative security	-	820 Added 10.46%	7,017 Common Stock
Aug 09 2021	SELL Open market or private sale	$1,036,068 $107.89 p/Share	9,603 Reduced 60.78%	6,197 Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$181,113 $18.86 p/Share	9,603 Added 37.8%	15,800 Common Stock
Aug 06 2021	SELL Open market or private sale	$578,663 $108.71 p/Share	5,323 Reduced 46.21%	6,197 Common Stock
Aug 06 2021	BUY Exercise of conversion of derivative security	$69,039 $12.97 p/Share	5,323 Added 31.6%	11,520 Common Stock
May 27 2021	SELL Payment of exercise price or tax liability	$97,127 $85.65 p/Share	1,134 Reduced 15.47%	6,197 Common Stock
May 27 2021	BUY Exercise of conversion of derivative security	-	3,279 Added 30.9%	7,331 Common Stock
May 17 2021	BUY Grant, award, or other acquisition	$19,761 $66.76 p/Share	296 Added 6.81%	4,052 Common Stock
Oct 13 2020	SELL Open market or private sale	$1,822,800 $121.52 p/Share	15,000 Reduced 79.97%	3,756 Common Stock
Oct 13 2020	BUY Exercise of conversion of derivative security	$282,900 $18.86 p/Share	15,000 Added 44.44%	18,756 Common Stock

Also insider at

AFIB

Acutus Medical, Inc. Healthcare

Director

JFS

John F Sheridan

PRESIDENT & CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNDM shares.

Notify only if

Value

Insider Trading

Get notified when an Tandem Diabetes Care Inc insider buys or sells TNDM shares.

Notify only if

Operation

Value

Type

News

Receive news related to TANDEM DIABETES CARE INC

Track Activities on TNDM

Account